Vericel Corp

VCEL Nasdaq CIK: 0000887359

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation MI
Business Address 64 SIDNEY ST., CAMBRIDGE, MA, 02139
Mailing Address 64 SIDNEY ST., CAMBRIDGE, MA, 02139
Phone 7349305555
Fiscal Year End 1231
EIN 943096597

Financial Overview

FY2025

$140.75M
Total Liabilities
$354.64M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 27, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
4 Insider stock transaction report March 25, 2026 View on SEC
DEF 14A Definitive proxy statement March 19, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report February 26, 2026 View on SEC
4 Insider stock transaction report February 26, 2026 View on SEC
4 Insider stock transaction report February 26, 2026 View on SEC
4 Insider stock transaction report February 26, 2026 View on SEC

Annual Reports

10-K February 26, 2026
  • Achieved strong financial performance in 2023 with 18% revenue growth and a significant turnaround to $15 million net income.
  • Successfully expanded NexoBrid's market presence and maintained consistent demand for Epicel, driving operational results.
View Analysis

Insider Trading

STRONG SELL 6 insiders 9 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.